Literature DB >> 10644750

Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium.

A Bonazzi1, V Mastyugin, P A Mieyal, M W Dunn, M Laniado-Schwartzman.   

Abstract

Hypoxic injury provokes inflammation of many tissues including the ocular surface. In rabbit corneal epithelial cells, both peroxisome proliferator-activated receptor (PPAR)-inducible cytochrome P450 4B1 and cyclooxygenase-2 (COX-2) mRNAs were increased by hypoxia. PPAR alpha and beta but not gamma mRNAs were detected in these cells. The PPAR activator, WY-14,643 increased COX-2 expression. Similarly, non-steroidal anti-inflammatory drugs with the ability to activate PPARs induced COX-2 independently of prostaglandin synthesis inhibition. COX-2 protein overexpression by hypoxia and PPAR activation was not associated with a parallel increase in prostaglandin E(2) accumulation. However, the enzyme regained full catalytic activity when: 1) hypoxic cells were re-exposed to normoxic conditions in the presence of heme and arachidonic acid, and 2) WY-14,643-treated cells were depleted of intracellular GSH. Consistent with previous observations showing that the corneal production of cytochrome P450-derived inflammatory eicosanoids is elevated by hypoxia and inflammation, the current data suggest that hypoxic injury is a model of inflammation in which molecules other than COX-derived arachidonic acid metabolites play a major proinflammatory role. This study also suggests that increased cellular GSH may be the mechanism responsible for the characteristic dissociation of PPAR-induced COX-2 expression and activity. Moreover, we provide new insights into the commonly observed lack of efficacy of classical non-steroidal anti-inflammatory drugs in the treatment of hypoxia-related ocular surface inflammation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10644750     DOI: 10.1074/jbc.275.4.2837

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Ocular cytochrome P450s and transporters: roles in disease and endobiotic and xenobiotic disposition.

Authors:  Mariko Nakano; Catherine M Lockhart; Edward J Kelly; Allan E Rettie
Journal:  Drug Metab Rev       Date:  2014-05-26       Impact factor: 4.518

2.  Biliverdin Rescues the HO-2 Null Mouse Phenotype of Unresolved Chronic Inflammation Following Corneal Epithelial Injury.

Authors:  Lars Bellner; Jesse Wolstein; Kiran A Patil; Michael W Dunn; Michal Laniado-Schwartzman
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-17       Impact factor: 4.799

3.  Genetic deletion of COX-2 diminishes VEGF production in mouse retinal Müller cells.

Authors:  Susan E Yanni; Gary W McCollum; John S Penn
Journal:  Exp Eye Res       Date:  2010-04-14       Impact factor: 3.467

Review 4.  Topical nonsteroidal anti-inflammatory drugs for ophthalmic use: a safety review.

Authors:  Bruce I Gaynes; Richard Fiscella
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

5.  Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.

Authors:  Thierry Claudel; Ekkehard Sturm; Hélène Duez; Inés Pineda Torra; Audrey Sirvent; Vladimir Kosykh; Jean-Charles Fruchart; Jean Dallongeville; Dean W Hum; Folkert Kuipers; Bart Staels
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

6.  Heme oxygenase-1 induction attenuates corneal inflammation and accelerates wound healing after epithelial injury.

Authors:  Kiran Patil; Lars Bellner; Giuseppe Cullaro; Katherine H Gotlinger; Michael W Dunn; Michal Laniado Schwartzman
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-25       Impact factor: 4.799

7.  Exacerbated corneal inflammation and neovascularization in the HO-2 null mice is ameliorated by biliverdin.

Authors:  Lars Bellner; Marco Vitto; Kiran A Patil; Michael W Dunn; Raymond Regan; Michal Laniado-Schwartzman
Journal:  Exp Eye Res       Date:  2008-06-17       Impact factor: 3.467

Review 8.  Hypoxia signaling to genes: significance in Alzheimer's disease.

Authors:  Nicolas G Bazan; Ricardo Palacios-Pelaez; Walter J Lukiw
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.682

9.  An ex vivo human aqueous humor-concentration comparison of two commercial bromfenac formulations.

Authors:  Thomas R Walters; Robert J Smyth-Medina; Paul C Cockrum
Journal:  Clin Ophthalmol       Date:  2018-05-21

10.  Metabolites Associated With Circulating Interleukin-6 in Older Adults.

Authors:  Michael S Lustgarten; Roger A Fielding
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-09-01       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.